Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy

BACKGROUND: The prescribed radiation dose to patients with oropharyngeal squamous cell carcinoma (OPSCC) is standardized, even if the prognosis for individual patients may differ. Easy-at-hand pre-treatment risk stratification methods are valuable to individualize therapy. In the current study we as...

Descripción completa

Detalles Bibliográficos
Autores principales: Adrian, Gabriel, Carlsson, Henrik, Kjellén, Elisabeth, Sjövall, Johanna, Zackrisson, Björn, Nilsson, Per, Gebre-Medhin, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195357/
https://www.ncbi.nlm.nih.gov/pubmed/35701827
http://dx.doi.org/10.1186/s13014-022-02074-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195357/
https://www.ncbi.nlm.nih.gov/pubmed/35701827
http://dx.doi.org/10.1186/s13014-022-02074-7

Ejemplares similares